Insider Trading Alert - FRX, CREE, IBKR And DIS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Jan. 24, 2014, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $199.71 to $33,314,419.42.

Highlighted Stocks Traded by Insiders:

Forest Laboratories (FRX) - FREE Research Report

Solomon Howard who is Director at Forest Laboratories sold 250,000 shares at $67.13 on Jan. 24, 2014. Following this transaction, the Director owned 714,881 shares meaning that the stake was reduced by 25.91% with the 250,000-share transaction.

The shares most recently traded at $65.28, down $1.85, or 2.83% since the insider transaction. Historical insider transactions for Forest Laboratories go as follows:

  • 12-Week # shares sold: 1,104
  • 24-Week # shares sold: 13,104

The average volume for Forest Laboratories has been 2.1 million shares per day over the past 30 days. Forest Laboratories has a market cap of $18.2 billion and is part of the health care sector and drugs industry. Shares are up 8.2% year-to-date as of the close of trading on Friday.

Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. The company has a P/E ratio of 118.4. Currently there are 11 analysts that rate Forest Laboratories a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FRX - FREE

TheStreet Quant Ratings rates Forest Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, solid stock price performance, impressive record of earnings per share growth and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Forest Laboratories Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cree (CREE) - FREE Research Report

Ruud Alan J who is Director at Cree sold 32,500 shares at $63.76 on Jan. 24, 2014. Following this transaction, the Director owned 1.1 million shares meaning that the stake was reduced by 2.84% with the 32,500-share transaction.

The shares most recently traded at $61.79, down $1.97, or 3.19% since the insider transaction. Historical insider transactions for Cree go as follows:

  • 4-Week # shares sold: 25,000
  • 12-Week # shares sold: 25,000
  • 24-Week # shares sold: 25,000

The average volume for Cree has been 2.1 million shares per day over the past 30 days. Cree has a market cap of $7.7 billion and is part of the technology sector and electronics industry. Shares are down 1.44% year-to-date as of the close of trading on Friday.

Cree, Inc. develops, manufactures, and sells lighting-class light emitting diode (LED), lighting, and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, South Korea, Japan, Malaysia, and Taiwan. The company has a P/E ratio of 65.3. Currently there are 6 analysts that rate Cree a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CREE - FREE

TheStreet Quant Ratings rates Cree as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cree Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Interactive Brokers Group (IBKR) - FREE Research Report

Nemser Earl H who is Vice Chairman at Interactive Brokers Group sold 15,248 shares at $22.24 on Jan. 24, 2014. Following this transaction, the Vice Chairman owned 145,015 shares meaning that the stake was reduced by 9.51% with the 15,248-share transaction.

Brody Paul Jonathan who is Chief Financial Officer at Interactive Brokers Group sold 8,478 shares at $22.74 on Jan. 24, 2014. Following this transaction, the Chief Financial Officer owned 80,624 shares meaning that the stake was reduced by 9.51% with the 8,478-share transaction.

The shares most recently traded at $21.84, down $0.90, or 4.1% since the insider transaction. Historical insider transactions for Interactive Brokers Group go as follows:

  • 4-Week # shares sold: 16,000
  • 12-Week # shares sold: 53,000
  • 24-Week # shares sold: 110,000

The average volume for Interactive Brokers Group has been 591,600 shares per day over the past 30 days. Interactive Brokers Group has a market cap of $1.1 billion and is part of the financial sector and financial services industry. Shares are down 9.53% year-to-date as of the close of trading on Friday.

Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. The stock currently has a dividend yield of 1.79%. The company has a P/E ratio of 26.0. Currently there are 2 analysts that rate Interactive Brokers Group a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBKR - FREE

TheStreet Quant Ratings rates Interactive Brokers Group as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Interactive Brokers Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Walt Disney (DIS) - FREE Research Report

Braverman Alan N who is Sr EVP, General Counsel & Secy at Walt Disney sold 4,334 shares at $74.26 on Jan. 24, 2014. Following this transaction, the Sr EVP, General Counsel & Secy owned 225,399 shares meaning that the stake was reduced by 1.89% with the 4,334-share transaction.

The shares most recently traded at $72.42, down $1.84, or 2.54% since the insider transaction. Historical insider transactions for Walt Disney go as follows:

  • 4-Week # shares sold: 39,401
  • 12-Week # shares sold: 49,401
  • 24-Week # shares sold: 49,401

The average volume for Walt Disney has been 6.5 million shares per day over the past 30 days. Walt Disney has a market cap of $131.4 billion and is part of the services sector and media industry. Shares are down 4.82% year-to-date as of the close of trading on Friday.

The Walt Disney Company operates as an entertainment company worldwide. The company operates in five segments: Media Networks, Parks and Resorts, Studio Entertainment, Consumer Products, and Interactive. The stock currently has a dividend yield of 1.15%. The company has a P/E ratio of 22.1. Currently there are 13 analysts that rate Walt Disney a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DIS - FREE

TheStreet Quant Ratings rates Walt Disney as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Walt Disney Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump